VMD Earnings & Financial Statements
Viemed Healthcare, Inc.
$9.52
+$0.11(+1.17%)
63
Overall
80
Value
54
Tech
57
Quality
Market Cap
$358.41M
Volume
152.49K
52W Range
$6.05 - $12.61
Target Price
$12.50
VMD earnings and financial statements: Viemed Healthcare, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
VMD Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $270.28M | $224.26M | $183.01M | $138.83M | $117.06M |
| Cost of revenue | $114.82M | $91.05M | $70.22M | $54.15M | $43.65M |
| Operating income | $20.46M | $16.17M | $14.78M | $7.61M | $12.03M |
| EBITDA | $51.79M | $43.80M | $36.80M | $24.62M | - |
| Net income | $14.93M | $12.56M | $18.66M | $6.22M | $9.13M |
| EPS (diluted) | $0.37 | $0.28 | $0.25 | $0.16 | $0.22 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $199.15M | $177.07M | $154.90M | $117.04M | $117.96M |
| Total liabilities | $55.63M | $43.77M | $41.00M | $19.95M | $23.14M |
| Shareholders’ equity | $141.54M | $131.39M | $113.89M | $97.09M | $94.82M |
| Cash and equivalents | $13.50M | $17.54M | $7.18M | $5.91M | $11.95M |
| Long-term debt | $11.29M | $3.59M | $6.13M | $199.0K | $4.57M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $51.92M | $39.09M | $45.21M | $27.75M | $22.49M |
| Free cash flow | $11.93M | $1.32M | $21.71M | $5.91M | $22.49M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VMD | $9.52 | +1.2% | 152.49K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |